Variant report
Variant | esv10952 |
---|---|
Chromosome Location | chr12:41028057-41028974 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:41018576..41021441-chr12:41028781..41031476,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs367889767 | chr12:41028089-41028090 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs138683526 | chr12:41028112-41028113 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs548465912 | chr12:41028134-41028135 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs78420988 | chr12:41028157-41028158 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs149350813 | chr12:41028162-41028163 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs552663226 | chr12:41028174-41028175 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs571285882 | chr12:41028266-41028267 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs538702495 | chr12:41028271-41028272 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs7309546 | chr12:41028338-41028339 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs182655074 | chr12:41028341-41028342 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs186628932 | chr12:41028408-41028409 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs554856204 | chr12:41028422-41028423 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs111679107 | chr12:41028442-41028443 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs540394417 | chr12:41028469-41028470 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs565075231 | chr12:41028534-41028535 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs376599799 | chr12:41028586-41028587 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs77141631 | chr12:41028602-41028603 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs191472429 | chr12:41028608-41028609 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs529998119 | chr12:41028624-41028625 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs113917326 | chr12:41028640-41028641 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs376977886 | chr12:41028641-41028642 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs200141029 | chr12:41028651-41028652 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs538529083 | chr12:41028652-41028653 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs566799038 | chr12:41028656-41028657 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs527960546 | chr12:41028678-41028679 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs376892400 | chr12:41028687-41028688 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs556805763 | chr12:41028724-41028725 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs183177117 | chr12:41028772-41028773 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs571762639 | chr12:41028774-41028775 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs571019900 | chr12:41028826-41028827 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs538394474 | chr12:41028827-41028828 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs556975805 | chr12:41028876-41028877 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs187809102 | chr12:41028894-41028895 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs568763214 | chr12:41028906-41028907 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Seminomas | 18059402 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Lissencephaly | 21572526 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Autism | 20858243 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Breast cancer | 19602461 | CNVD |
Breast cancer | 17899364 | CNVD |
Cancer | 20164920 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 21364760 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:41027400-41028600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr12:41027400-41028600 | Weak transcription | Fetal Lung | lung |
3 | chr12:41027400-41029200 | Enhancers | A549 | lung |
4 | chr12:41027800-41028800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
5 | chr12:41028000-41028400 | Weak transcription | Aorta | Aorta |
6 | chr12:41028400-41028800 | Enhancers | Aorta | Aorta |
7 | chr12:41028600-41029000 | Enhancers | Gastric | stomach |
8 | chr12:41028600-41029200 | Enhancers | Brain Dorsolateral Prefrontal Cortex | brain |
9 | chr12:41028600-41029200 | Enhancers | Fetal Kidney | kidney |
10 | chr12:41028600-41029400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr12:41028600-41029400 | Enhancers | Fetal Lung | lung |